HCA Healthcare Stock Declines After Cutting Full-Year Profit Guidance

HCA Healthcare (NYSE: HCA) shares fell sharply on Tuesday after the hospital operator cut its full-year profit forecast, citing a deteriorating mix of insured and uninsured patients. The negative outlook overshadowed a preliminary report of stronger-than-expected revenue for the second quarter, signaling investor concern over future profitability.

Guidance Cut Overshadows Revenue Beat

HCA announced it was lowering its fiscal 2026 earnings guidance, causing investors to sell off the stock despite a strong top-line performance. The company attributed the revision to a "worsening payer mix" as more patients lose coverage through health insurance exchanges.

Key details from the financial update include:

• Full-Year 2026 EPS Guidance: Lowered to $28.70–$30.50 per share, from a prior range of $29.10–$31.50.
• Full-Year 2026 Adjusted EBITDA: Trimmed to $15.4 billion–$16.1 billion, from $15.55 billion–$16.45 billion previously.
• Preliminary Q2 Revenue: Reported at approximately $20.23 billion, beating the consensus estimate of $19.39 billion and up from $18.61 billion a year earlier.

The company noted that its second-quarter results included an incremental benefit of approximately $400 million from Medicaid Supplemental Payment Programs. However, this one-time item was not enough to offset the structural concerns about the forward-looking payer mix.

Market Reaction and Analyst Revisions

Ad

In morning trading on July 14, shares of HCA Healthcare fell 6.6% to $365.07. The sell-off was specific to the company's announcement, as the broader U.S. equity market saw gains, with the S&P 500 edging up 0.3%.

In response to the revised outlook, several Wall Street analysts adjusted their price targets. According to Investing.com, KeyBanc lowered its target to $475 from $510 while maintaining an Overweight rating, and Wells Fargo cut its target to $428 from $436, keeping an Equal Weight rating.

Broader Industry Implications

The commentary from HCA, a bellwether for the hospital sector, has raised concerns about the operating environment for its industry peers. A rising proportion of uninsured patients can significantly pressure hospital margins, as care for this group is often uncompensated or reimbursed at lower rates.

CEO Sam Hazen acknowledged the challenges, stating the company had "adjusted our guidance to reflect these factors," while expressing confidence in HCA's ability to navigate the environment, Investing.com reported.